Hepatitis C inhibitor compounds
US7585845B2 · kind B2 · utility
21Cited by
35References
67Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 2004 |
| Grant date | Sep 8, 2009 |
| Priority date | — |
| Expiry date | Oct 20, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I):wherein B, X, R3, L0, L1, L2, R2, R1 and RC are defined herein. The compounds are useful as inhibitors of HCV NS3 protease for the treatment of hepatitis C viral infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.